Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
XERS
XERS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
XERS News
Xeris Biopharma Projects 2026 Revenue Guidance Above Consensus
Mar 02 2026
seekingalpha
Xeris Biopharma Reports Record Revenue Growth and Profitability in Q4 2025
Mar 02 2026
seekingalpha
Xeris Pharmaceuticals Q4 Earnings Beat Expectations
Mar 02 2026
seekingalpha
Wall Street's First Trading Day of March Outlook
Mar 01 2026
CNBC
Xeris Biopharma Shares Drop Amid Patent Infringement Lawsuit
Feb 27 2026
Benzinga
Xeris Pharmaceuticals to Announce Q4 Earnings on March 2
Feb 27 2026
seekingalpha
Xeris Biopharma Files Patent Infringement Lawsuit Against Generic Competitors
Feb 26 2026
Businesswire
Xeris Biopharma to Release Q4 and Full Year 2025 Financial Results
Feb 17 2026
Businesswire
Xeris Biopharma to Release 2025 Financial Results
Feb 17 2026
Newsfilter
Analyst Target Prices Indicate Potential for Pharmaceuticals ETF
Jan 29 2026
NASDAQ.COM
Xeris Anticipates 2025 Revenue of $292 Million, Exceeding Guidance
Jan 08 2026
Newsfilter
Outlook Therapeutics Inc Faces 60.9% Drop After FDA Response on ONS-5010
Jan 02 2026
Benzinga
Xeris Biopharma Shares Surge 7.59% as Competitor Corcept's FDA Approval Fails
Jan 01 2026
Fool
Xeris Biopharma Gains 7% as Corcept's FDA Setback Boosts Investor Sentiment
Jan 01 2026
NASDAQ.COM
Xeris Biopharma (XERS) Drops 9.3% Following XP-8121 Patent Milestone Announcement – Is the Bullish Outlook Still Valid?
Dec 06 2025
Yahoo Finance
Xeris Biopharma Holdings (XERS) Experiences Oversold Conditions
Dec 02 2025
NASDAQ.COM
Show More News
